Astonea Labs Ltd.
Fundamentals
- Market cap
- ₹276 cr
- P/E
- 61.13×
- ROE
- 29.06%
- Debt / equity
- 2.90
- 52-week range
- 118.00 — 301.30
Company snapshot
Astonea Labs Ltd.
Pharmaceuticals
₹292 cr
P/E 64.72×
Latest quarter · Mar 2026
Sales₹81 cr
Net profit₹3 cr
Op. margin+9.8%
EPS₹2.95
Strength & growth
Debt / equity2.90×
Current ratio1.12×
The timeline — 3 notes on Astonea Labs Ltd.
July 2026
- 17 Jul 26 · 6:14 PM IST Brief Brief · Micro cap
Astonea Labs raises ₹2.99 cr from Gurugram property sale
The nano-cap pharma seller unloaded two commercial units in JMD Megapolis IT Park to the Satija family. At just 1% of market cap, it's a modest cash boost.
- 14 Jul 26 · 7:01 PM IST Brief Brief · Regulatory · Micro cap
Astonea Labs passes Yemeni drug regulator's facility inspection
Panchkula plant cleared by SBDMA, opening doors for product registration and exports to Yemen, but no orders or revenue disclosed yet.